Loading...

World-Class Retina Care. Community-Based Caring.

July is UV Safety Month — Debunking Seven Common Myths About Sunglasses

Posted On July 8, 2025 / By / Posted in Blog

July is UV Safety Month — Debunking Seven Common Myths About Sunglasses

When most people think of UV protection, they think of their skin and sunscreen. Did you know that long-term exposure to bright sunlight may also increase your risk of eye disease? July

read more
Posted On June 24, 2025 / By / Posted in Blog

June is Fireworks Eye Safety Awareness Month

Summer is here, and for many that means outdoor celebrations that include fireworks, especially around the 4th of July. Unfortunately, this also means an increase in eye injuries. Here are a few

read more
Posted On / By / Posted in Blog

Dr. Abbey Presented Study Results of Two Investigational Wet AMD Treatments at Clinical Trials Summit

This past weekend, Texas Retina’s Director of Clinical Research for Dallas Ashkan M. Abbey, MD, led two presentations at the annual Clinical Trials at the Summit (CTS) meeting in Las Vegas, which

read more
Posted On June 16, 2025 / By / Posted in Blog

Initial Results of Phase Ib LOTUS Clinical Trial on Potential New Diabetic Macular Edema Treatment Released

On June 9, 2025, Eluminex Biosciences Limited, a clinical-stage protein therapeutics company, announced positive topline safety, tolerability, and pharmacodynamic data from the multicenter LOTUS Part 1 clinical trial of EB-105 in patients

read more
Posted On June 8, 2025 / By / Posted in Blog

Dr. Wang Featured in New Retina Radio Podcast

Texas Retina’s Robert C. Wang, MD, was interviewed about his presentation at the Association for Research in Vision and Ophthalmology (ARVO) 2025 Meeting for an episode of the New Retina Radio podcast

read more
Posted On June 5, 2025 / By / Posted in Blog

Dr. Abbey Discusses How Vorolanib Could Shift the Treatment Approach for Diabetic Macular Edema in New Retinal Physician Article

Texas Retina’s Ashkan M. Abbey, MD, served as a principal site investigator for the Phase II VERONA clinical trial evaluating the efficacy and safety of the vorolanib intravitreal insert (EYP-1901) in diabetic

read more
Posted On May 29, 2025 / By / Posted in Blog

When Should You See a Retina Specialist?

Your ophthalmologist or optometrist can monitor your vision, prescribe glasses and contact lenses, and diagnose, treat and prevent a number of eye diseases. However, for some eye conditions, your eye doctor may

read more
Posted On May 21, 2025 / By / Posted in Blog

Can Ozempic Affect Your Eyes or Vision?

Initially approved by the U.S. Food and Drug Administration (FDA) to help control blood sugar and treat type 2 diabetes, semaglutide (brand names Ozempic, Wegovy and Rybelsus) has also emerged as a

read more
Posted On May 14, 2025 / By / Posted in Blog

Texas Retina Associates Participating in Phase III Clinical Trial for Choroidal Melanoma

Under the leadership of principal investigator Timothy Fuller, MD, Texas Retina is participating in the Phase III AU-011 clinical trial (CoMpass) for treatment of small choroidal (ocular) melanoma. Together with Aura Biosciences,

read more
Posted On May 13, 2025 / By / Posted in Blog

Dr. Wang Presented Study Results of New Wet AMD Treatment Approach at the ARVO 2025 Meeting

On May 9, 2025, Texas Retina’s Robert C. Wang, MD, presented “Top Line Results from ODYSSEY: A Phase IIb Study of Suprachoroidally Administered CLS-AX in Participants with Neovascular Age-related Macular Degeneration” at

read more